Document:

exv10w61

Exhibit 10.61

THIS EMPLOYMENT AGREEMENT IS MADE

BETWEEN

Biogen Idec Management Services GmbH

c/o Baumeler Treuhand AG

Poststrasse 18

6300 Zug

(Biogen)

And

Hans-Peter Hasler

Ginsterweg 5

Kuessnacht a.R. 6403

(you)

This Agreement sets out the terms and conditions of your contract of employment with Biogen. The
provisions of this Agreement supersede and replace those contained in any document, correspondence
or communication, written or oral, exchanged between the parties prior to the signature of this
Agreement and relating to the purpose hereof.

1. EMPLOYMENT

	1.1	 	Biogen will employ you and you will provide management services to Biogen Idec International
GmbH and management services to Biogen Idec Inc. (Biogen Idec) as its Chief Operating Officer.
Special conditions (if any) applicable to your employment are set out in Schedule 1 to this
Agreement.
	 
	1.2	 	You will be responsible for Biogen Group global commercial operations and business
development. This includes the overall direction of the sales staff, including joint
ventures, distributors, and marketing partners. It also includes responsibility for
marketing, product positioning, business analysis and competitive market intelligence.
	 
	 	 	Furthermore, you will be responsible for customer service and support, and product
reimbursement relationships with private, public, and governmental
payors. Your responsibilities include assigned revenue goals, as well as operating margins and the
management of the expense budget, and in addition, the management and development of all
commercial employees in assigned organizations.
	 
	1.3	 	You will at all times during the Employment use your entire working capacity for the benefit
and interest of the Biogen Group. You will work the hours necessary or appropriate from time
to time to carry out your duties properly and effectively. No overtime will be payable. This
does not preclude you from sitting on other company

 

 

	 	 	boards in accordance with Company policies and procedures.
	 
	1.4	 	You shall report to the Chief Executive Officer of Biogen Idec.
	 
	1.5	 	You will be authorised to sign for Biogen and Biogen Idec International GmbH only while you
are in Switzerland. This signatory power shall be entered in the commercial register. You
are entitled to sign for Biogen Idec and other United States companies in the Biogen Group
pursuant to the Biogen Idec signature authority policy only while you are in the United
States.

2. EFFECTIVE DATE, TERM

	2.1	 	The Employment will begin on 26 June 2008. Your period of continuous employment with the
Biogen Group commenced on 1 August 2001.
	 
	2.2	 	The Employment will be subject to clauses 9 and 2.3 and will continue unless or until
terminated by either party giving to the other in writing not less than one month’s notice.
	 
	2.3	 	Biogen shall be entitled during any notice period (whether notice has been given by Biogen or
by you) to:

	 	2.3.1	 	Require you not to attend any premises of Biogen or any Group Company
	 
	 	2.3.2	 	Restrict your access to Biogen or any Group Company’s computer system or its
or their employees, customers and suppliers for any purposes related to Biogen or any
Group Company’s business and
	 
	 	2.3.3	 	Suspend you from the performance of any duties and obligations under this
Agreement.

3. PLACE OF WORK

Initially, the place of activity for the performance of your duties under the present agreement
shall, but not exclusively, be in the offices of Biogen in Switzerland. The place of activity
shall not be restricted to these offices but may be at any other place, in Switzerland or
abroad, in which you exercise your functions. The Employment implies frequent travel around the
world. You will keep track of the days you work in each country and provide the tax group with a
report quarterly. You will relocate to the Biogen Group US Headquarters location before 31
December 2009 and will transfer your employment to Biogen Idec and transfer to the United States
payroll and benefits in conjunction with your relocation. If you have not relocated by 30 June
2009, you agree to provide the CEO of Biogen Idec with a written declaration that includes a
definitive and detailed plan for your relocation. If you do not provide a written declaration
by 30 June 2009 of your plan to relocate and/or fail to relocate by 31 December 2009, it will
not be deemed a breach of the Agreement; however, Biogen reserves the right to take appropriate
employment action, including but not limited to

 

 

removing you from the COO position and/or terminating the employment relationship. It is
expected that when you relocate to the Biogen Group US Headquarters location a new employment
agreement will be entered into that will supersede this Agreement and will be governed by US
law.

4. ANNUAL SALARY

	4.1	 	Your initial annual base salary is CHF 725,000 (less any deduction require by law) payable in
arrears in 12 equal monthly installments at the end of each calendar month. The first time
you will be eligible for consideration of a base salary increase is 1 January 2009. After 1
January 2009, the annual base salary will be reviewed annually during the Employment. Biogen
is under no obligation to increase your salary following an annual base salary review. You
will be eligible for long-term incentive grants in 2009 and in all subsequent years, pursuant
to the policies in place during each year.
	 
	4.2	 	You shall not be entitled to any additional salary in respect to overtime worked.
	 
	4.3	 	You may, during the Employment, be granted rights upon the terms and subject to the
conditions of the rules from time to time of certain profit sharing, share incentive, share
option, bonus or phantom option schemes operated by Biogen or any Group Company with respect
to shares in Biogen or any Group Company (the Schemes). You acknowledge that such
participation is discretionary and the subject matter of an entirely separate arrangement with
the grantor of such rights. With the exception of the acceleration rights outlined in the
Biogen Inc. 1985 Non-Qualified Stock Option Plan and related documents, you shall not be
entitled to any compensation for the loss of any rights or benefits under any of the Schemes
on termination of the Employment, however arising.
	 
	4.4	 	During the term of this Agreement through 31 December 2009, if you continue to be a Biogen or
any Group Company employee, you will continue to receive the level of compensation enumerated
in this Agreement.

5. EXPENSES

	 	 	Biogen will reimburse any travelling, hotel, entertainment and other out-of-pocket
expenses properly and reasonably incurred by you in connection with the discharge of your
duties of Employment and in accordance with Biogen’s instructions and general guidelines
and procedures.

6. HOLIDAYS

	6.1	 	You are entitled to 25 Working Days Holiday (in addition to statutory holidays), with full
salary in each calendar year. Holiday entitlement may be carried forward to a future calendar
year but such carry over may not exceed 5 days and the holiday carried over

 

 

	 	 	must be used by 31st March in that future calendar year. If you start or leave
your employment during a calendar year, Biogen holiday entitlement in respect of that
calendar year will be calculated on a pro rata basis. On the termination of the Employment,
you will be entitled to pay in lieu of outstanding holiday entitlement (if any) but must
repay any holiday pay received for holiday taken in excess of your actual entitlement.
	 
	6.2	 	You will be entitled to the public holidays at the registered office of Biogen. However, if
you are not present at the registered office of Biogen on the date of a public holiday you
will not be entitled to take an extra day off on another date. Furthermore, should a day
which is a working day at the registered office of Biogen be a public holiday at another
location where you are effectively present at that date, then you will be entitled to a day
off which will not count as vacation.

7. PERIODS OF ABSENCE, SICKNESS

	7.1	 	You shall advise Biogen promptly of any absence from work and the foreseeable duration of
such absence.
	 
	7.2	 	If you are absent from work due to sickness or injury, Biogen will pay your salary in
accordance with the Swiss legislation in force at the time of absence.

8. PENSION, INSURANCE, AND OTHER BENEFITS

	8.1	 	You shall be eligible during the Employment to participate in Biogen’s benefit plans
including retirement, death, disability, accidental death and dismemberment coverage, business
travel insurance, and gym membership contributions from time to time in force subject to the
terms, conditions and rules of the providers of such benefits. Details of these policies can
be obtained from Biogen. Biogen may, at its absolute discretion, modify or terminate any of
these benefits at any time.

9. SUMMARY DISMISSAL

	9.1	 	Biogen Group may terminate the Employment summarily without notice (but without prejudice to
its rights and remedies for any remedies for any breach of this Agreement by you) if:

	 	(a)	 	you engage in misconduct that is injurious to Biogen Group monetarily or otherwise,
	 
	 	(b)	 	you are convicted of a felony by a court of competent jurisdiction,

 

 

	 	(c)	 	you commit an act of fraud or embezzlement relating to the property of Biogen
Group,
	 
	 	(d)	 	you violate any obligations of confidentiality or nondisclosure owed to Biogen
Group, or
	 
	 	(e)	 	you commit any material breach of any of the terms of this Agreement or you do
not comply with Section 3 of this Agreement.

10. RESTRAINT OF ACTIVITIES OF EMPLOYEE

	10.1	 	You agree not to engage in any other professional activity, either on your own account or on
the account of a third party, including accepting any position as director or legal
representative in a company, which is not a Group Company, except with our prior written
consent.
	 
	10.2	 	You further agree to not, directly or indirectly, take an interest in any company or firm
having an activity that is in competition with or complementary to that of the Company or any
Group Company. However, such prohibition shall not apply to investments in listed companies or
investment funds, as long as your interest does not exceed 5% of the share capital or voting
rights of such companies or investment funds. You agree to comply with this covenant for the
entire term of your agreement, including during the notice period, even if we agree to waive
the notice period.
	 
	10.3	 	During the term of your employment and for a period of two (2) years following the separation
of your employment with the Company, regardless of the reason for such separation, you will
neither (i) offer employment to or hire any Company employee, whether for your own benefit or
for the benefit of another person or entity (nor shall you assist any other in doing so) nor
(ii) solicit, entice or persuade any employee to leave the Company.

11. CONFIDENTIALITY

11.1 You are subject to obligations of loyalty and confidentiality and, accordingly, you agree in
particular to observe the utmost discretion in all matters relating to the activities of the Biogen
Idec Group and its clients and to not disclose, at any time during your employment within the
Biogen Group or at any time after its termination, for whatever cause, any information of a secret
or confidential nature relating to the business of the Company, any Group Company or its clients.
You undertake to return to the Company, upon your departure, all documents (including copies)
relating to your employment. Confidential information includes, without limitation, any financial
or technical information, reports or forecasts, databases and market-related plans, consumer,
patient or practitioner lists, business plans, projects, contacts, medical publications, medical,
pharmaceutical or chemical formulae or biological processes, or opportunities discussed

 

 

during your employment. You acknowledge that disclosure of such information would cause serious
damage to the Company.

11.2 You undertake not to offer, even after your departure, to any competitor company any
proprietary information of the Company or the Biogen Idec Group that you have obtained in the
course of your duties or through your presence within the Company.

12. COMPANY DOCUMENTS AND PROPERTY

	12.1	 	All property, including emails, books, papers, materials, documents and photocopies or
electronic versions, which relate to the business of Biogen or any Group Company is and shall
remain the property of Biogen or the appropriate Group Company. You must return this property
at Biogen’s first request, or in any event upon suspension from work or termination of the
Employment.
	 
	12.2	 	Business records of any kind, including private notes concerning Biogen’s and any Group
Company’s affairs and activities, shall be carefully kept and shall be used only for business
purposes. Copies or extracts of drawings, notes, calculations, statistics and the like as
well as any other business documents are only permitted for business purposes.

13. INTELLECTUAL PROPERTY

	13.1	 	In this Agreement, the Intellectual Property Rights means copyrights, patents, utility
models, trade marks, service marks, design rights (whether registered or unregistered),
database rights, know how, trade or business names and other similar rights or obligations
whether registrable or not in any country.
	 
	13.2	 	All Intellectual Property Rights arising in the course of or as a consequence of the
employment or other work undertaken by you for Biogen or any Group Company under this
agreement shall belong to Biogen or the relevant Group Company.
	 
	13.3	 	You hereby assign to Biogen by way of future assignment all copyrights or other Intellectual
Property Rights arising under clause 13.2 (and waive any equivalent moral rights) immediately
on their coming into existence.

14. DATA PROTECTION

	14.1	 	In this clause, the following terms are defined as follows:
	 
	 	 	Personal Data means any information about you, including but not limited to your name,
address, references, bank details, salary, stock options, performance appraisals, work
skills and career achievements, vacation, other benefits, sickness, work records,

 

 

	 	 	management and organizational appraisals and data held for employment law purposes, and
shall include information about any next of kin, if appropriate, and/or other persons about
whom data may be collected.
	 
	 	 	Processing shall mean carrying out any operation or set of operations on Personal Data
including, but not limited to, obtaining, organizing, consulting, using, disclosing or
destroying.
	 
	14.2	 	You acknowledge that Biogen, by itself or through third parties, will Process Personal Data
and that this Personal Data may be used for personnel, administration and management purposes
in connection with your employment or the administration of post-employment benefits to comply
with any obligations that Biogen or any Group Company may have regarding the retention of
employee/worker records and for any other legitimate interests of Biogen and/or Group Company.
	 
	14.3	 	You further understand and agree that Personal Data may if necessary for the abovementioned
purposes, be transferred to third parties, including other Group companies, their advisors,
third parties providing products and services, such as IT systems suppliers, pension,
benefits, stock options and payroll administrators, as well as regulatory authorities
(including tax authorities), as required by law and relevant stock exchange rules. You agree
that Biogen may Process Personal Data in the country where you are employed and in other
countries, including in the U.S. You also understand that some of the countries outside the
EEA to which your Personal Data may be transferred may not offer a similar level of protection
with respect to privacy of personal data as that granted in Switzerland.
	 
	14.4	 	You understand that you should contact Biogen Human Resources with any queries that you may
have about your Personal Data.
	 
	14.5	 	By signing this employment agreement, you expressly consent to the Processing and transfer of
Personal Data during and after your employment.

15. MISCELLANEOUS

	15.1	 	Changes and/or amendment to this agreement shall only be valid if made in writing and duly
signed by both parties hereto. The same holds true for any change or amendment of this clause
15.1. In addition, Sections 10 through 17 of this Agreement shall survive the termination of
this Agreement.
	 
	15.2	 	Reference is made in this Agreement to various Company policies rules and procedures. These
are discretionary and do not create contractual rights for employees; however, any Company or
Group Company policy must be adhered to by you at all times and can be amended, replaced or
terminated at any time by Biogen without giving any reasons.

 

 

	15.3	 	If any term or provision of this Agreement is held to be illegal or unenforceable under any
enactment or rule of law, such term or provision or part thereof shall to that extent be
deemed not to form part of this Agreement but the enforceability of the remainder of this
Agreement shall not be affected thereby. The void and unenforceable provision shall be
replaced by the parties by a valid and enforceable provision which in its economic effect
comes closest to the replaced provision.
	 
	15.4	 	Notice under these terms and conditions will be treated as having been given if sent by
ordinary first class post, by you to Biogen’s registered office or by Biogen to you at your
last known address, as appropriate, and will be deemed to be given on the day when it would
ordinarily be delivered after such posting. Any notice to be given under this Agreement to
you may also be served by being handed to you personally.

16. APPLICABLE LAW

16.1 This Agreement and its interpretation shall be governed by the laws of Switzerland.

16.2 The courts of your Canton of residence shall have jurisdiction for the resolution of any
dispute in connection with the Employment, which cannot be settled amicably.

16.3 Notwithstanding any other provision of this Agreement, to the extent required by Section 409A
of the United States Internal Revenue Code of 1986, as amended and the applicable regulations and
guidance thereunder (“Section 409A”), if you are a “specified employee” (as defined in Section
409A), payments on account of a separation from service (within the meaning of Section 409A) shall
not be made to you before the date which is six months after the date on which you separate from
service or, if earlier, your date of death; except to the extent of amounts that do not constitute
a deferral of compensation under Section 409A.

17. DEFINITIONS

	17.1	 	Biogen Group means Biogen and any Group Company;
	 
	17.2	 	Group Company means any of:

	 	(i)	 	Biogen;
	 
	 	(ii)	 	Any holding company from time to time of Biogen;
	 
	 	(iii)	 	Any direct or indirect subsidiary or parent from time to time of Biogen or any
such holding company, including Biogen Idec;

	17.3	 	The Employment means the employment established by the Agreement.

 

 

	 	 	 	 	 	 	 
	 

	 	 	 	“I acknowledge receipt of a duplicate
copy for the agreement and confirm my
agreement to it.”	 	 
	 
	 	 	 	 	 	 
	/s/ James Mullen
 

Jim Mullen, CEO and President 

Signed for and on behalf of

Biogen Idec Management Services GmbH

	 	 	 	/s/ Hans Peter Hasler
 

Signed by Hans Peter Hasler
	 	 
	 
	 	 	 	 	 	 
	     10/15/08

	 	 	 	     October 15, 2008	 	 
	Date

	 	 	 	Dateexv10w63

Exhibit 10.63

FIRST AMENDMENT TO

EMPLOYMENT AGREEMENT

     THIS AMENDMENT by and between BIOGEN IDEC INC., (the “Company”), and Cecil B. Pickett (the
“Executive”), dated as of October 28, 2008.

     WHEREAS, the Executive and the Company are parties to an Employment Agreement dated as of June
21, 2006 (the “June 21, 2006 Agreement”); and

     WHEREAS, the Executive and the Company desire to amend the June 21, 2006 Agreement as set
forth herein.

     NOW, THEREFORE, it is hereby agreed as follows:

	 	1.	 	Attachment D of the June 21, 2006 Agreement is hereby amended and restated in
the following manner:

	 	•	 	Strike the phrase in the first paragraph “which is not promptly cured after
written notice.”
	 
	 	•	 	Add the following language to the end of the first paragraph:
	 
	 	 	 	; or (F) an Involuntary Employment Action as defined in connection with a Corporate
Transaction or Change in Control (defined in the 2008 Omnibus Plan). Prior to your
termination of employment, you must notify the Chief Legal Counsel or the Head of
Human Resources of Biogen Idec in writing of the basis you are terminating your
employment in connection with sections (A) through (F) of this paragraph. This
written notice must be given to the Company within one year of the circumstances
giving rise to you terminating your employment and Biogen Idec will have up to 30
days after the date of your notice to cure such circumstances.

Signed:

	 	 	 	 	 	 	 
	/s/ Cecil B. Pickett
 

Cecil B. Pickett (Executive)

	 	 	 	     10/28/08
 

Date
	 	 
	 
	 	 	 	 	 	 
	/s/ Craig E. Schneier
 

Craig E. Schneier (on behalf of the Company)

	 	 	 	     10/30/08
 

Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}]]